CIAM
ATYR

Caitong International Asset Management’s aTyr Pharma ATYR Stock Holding History

Caitong International Asset Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 2931
2026
Q1 		$1 Sell
1
-66
-99% -$56 ﹤0.01% 2526
2025
Q4 		$52 Hold
67
– – ﹤0.01% 1753
2025
Q3 		$48 Sell
67
-1,853
-97% -$8.4K ﹤0.01% 1816
2025
Q2 		$9.73K Buy
1,920
+524
+38% +$2.06K 0.01% 738
2025
Q1 		$4.22K Buy
+1,396
New +$5.09K ﹤0.01% 1068

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caitong International Asset Management's ATYR Position: Q2 2026 in Review

Caitong International Asset Management held its aTyr Pharma (ATYR) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2931.

Caitong International Asset Management first reported a position in ATYR in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.73K in Q2 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Caitong International Asset Management held 1 share of aTyr Pharma worth $1 as of Q2 2026.
  • Caitong International Asset Management left its aTyr Pharma share count unchanged in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2931 holding.
  • Caitong International Asset Management first reported a position in aTyr Pharma in Q1 2025 and has held it in 6 quarters since.
  • Caitong International Asset Management's aTyr Pharma position peaked at $9.73K in Q2 2025.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.